Martina Ceckova Selected Research

6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurine

1/2016	Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
1/2013	Olomoucine II, but not purvalanol A, is transported by breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1).
1/2013	Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina Ceckova Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2006
13	Neoplasms (Cancer) 01/2022 - 12/2008
3	Choriocarcinoma 09/2020 - 01/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 06/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	HIV Infections (HIV Infection) 09/2020 - 01/2014
1	Melanoma (Melanoma, Malignant) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 06/2020
1	Cardiotoxicity 01/2019
1	Leukemia 01/2019
1	Cholestasis 05/2015
1	Carcinoma (Carcinomatosis) 01/2013
1	Tuberculosis (Tuberculoses) 01/2007

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 01/2022 - 01/2006
14	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2006
10	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 01/2006
9	Adenosine Triphosphate (ATP)IBA 01/2019 - 12/2008
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 03/2012
5	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 10/2006
4	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019 - 01/2013
3	EnzymesIBA 11/2019 - 01/2019
3	olomoucine IIIBA 01/2016 - 01/2013
3	Multidrug Resistance-Associated ProteinsIBA 01/2016 - 11/2015
3	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 01/2016 - 01/2013
2	Maraviroc FDA Link 09/2020 - 01/2019
2	multidrug resistance-associated protein 1IBA 09/2020 - 07/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2019 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 11/2019 - 01/2019
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 01/2013
2	Multidrug Resistance-Associated Protein 2IBA 11/2015 - 01/2014
2	purineIBA 01/2013 - 03/2012
1	midostaurinIBA 06/2022
1	Drug CombinationsIBA 01/2022
1	dabrafenibIBA 01/2022
1	brivanibIBA 11/2019
1	Cytostatic AgentsIBA 01/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2019
1	daunorubicinolIBA 01/2019
1	alectinibIBA 01/2019
1	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	Chemokine ReceptorsIBA 01/2019
1	ribociclibIBA 01/2018
1	dinaciclibIBA 12/2015
1	abacavir (Ziagen)FDA Link 11/2015
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 07/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2015
1	alvocidib (flavopiridol)IBA 07/2015
1	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 07/2015
1	boldineIBA 05/2015
1	ProdrugsIBA 01/2014
1	Tenofovir (Viread)FDA Link 01/2014
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	RoscovitineIBA 01/2013
1	AnionsIBA 11/2012
1	CationsIBA 11/2012
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2006
1	XenobioticsIBA 01/2006

Therapy/Procedure

4	Therapeutics 11/2019 - 12/2015
3	Drug Therapy (Chemotherapy) 06/2020 - 02/2011
1	Polypharmacy 01/2022
1	Drug Tapering 01/2013